Literature DB >> 9725470

In vitro study of the binding of doxorubicin to heart.

L Alvarez-Cedrón1, F G López, J M Lanao.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9725470     DOI: 10.1007/BF03189328

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.569


× No keyword cloud information.
  21 in total

Review 1.  Methods of determining plasma and tissue binding of drugs. Pharmacokinetic consequences.

Authors:  G M Pacifici; A Viani
Journal:  Clin Pharmacokinet       Date:  1992-12       Impact factor: 6.447

2.  Pharmacokinetics and metabolism of iodo-doxorubicin and doxorubicin in humans.

Authors:  K Mross; U Mayer; K Hamm; K Burk; D K Hossfeld
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

3.  Development and identification of a multicompartment model for the distribution of adriamycin in the rat.

Authors:  P Sonneveld; J A Mulder
Journal:  J Pharmacokinet Biopharm       Date:  1981-10

4.  Effect of verapamil on doxorubicin cardiotoxicity: altered muscle gene expression in cultured neonatal rat cardiomyocytes.

Authors:  H Akimoto; N A Bruno; D L Slate; M E Billingham; S V Torti; F M Torti
Journal:  Cancer Res       Date:  1993-10-01       Impact factor: 12.701

5.  Enzymatic defenses of the mouse heart against reactive oxygen metabolites: alterations produced by doxorubicin.

Authors:  J H Doroshow; G Y Locker; C E Myers
Journal:  J Clin Invest       Date:  1980-01       Impact factor: 14.808

6.  Doxorubicin cardiomyopathy is associated with a decrease in calcium release channel of the sarcoplasmic reticulum in a chronic rabbit model.

Authors:  D A Dodd; J B Atkinson; R D Olson; S Buck; B J Cusack; S Fleischer; R J Boucek
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

7.  Prevention of doxorubicin-induced myocardial and haematological toxicities in rats by the iron chelator desferrioxamine.

Authors:  M M al-Harbi; N M al-Gharably; O A al-Shabanah; A M al-Bekairi; A M Osman; H N Tawfik
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

8.  Comparison of different iron chelators as protective agents against acute doxorubicin-induced cardiotoxicity.

Authors:  E E Voest; S A van Acker; W J van der Vijgh; B S van Asbeck; A Bast
Journal:  J Mol Cell Cardiol       Date:  1994-09       Impact factor: 5.000

9.  A deletion of mitochondrial DNA in murine doxorubicin-induced cardiotoxicity.

Authors:  K Adachi; Y Fujiura; F Mayumi; A Nozuhara; Y Sugiu; T Sakanashi; T Hidaka; H Toshima
Journal:  Biochem Biophys Res Commun       Date:  1993-09-15       Impact factor: 3.575

10.  Ascorbic acid and adriamycin toxicity.

Authors:  K Shimpo; T Nagatsu; K Yamada; T Sato; H Niimi; M Shamoto; T Takeuchi; H Umezawa; K Fujita
Journal:  Am J Clin Nutr       Date:  1991-12       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.